Cargando…
Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines
One of the most promising photosensitizers (PS) used in photodynamic therapy (PDT) is the porphyrin derivative 5,10,15,20-tetra(m-hydroxyphenyl)chlorin (mTHPC, temoporfin), marketed in Europe under the trade name Foscan(®). A set of five human cancer cell lines from head and neck and other PDT-relev...
Autores principales: | Lange, Carsten, Lehmann, Christiane, Mahler, Martin, Bednarski, Patrick J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587334/ https://www.ncbi.nlm.nih.gov/pubmed/31117328 http://dx.doi.org/10.3390/cancers11050702 |
Ejemplares similares
-
Evaluation for Synergistic Effects by Combinations of Photodynamic Therapy (PDT) with Temoporfin (mTHPC) and Pt(II) Complexes Carboplatin, Cisplatin or Oxaliplatin in a Set of Five Human Cancer Cell Lines
por: Lange, Carsten, et al.
Publicado: (2018) -
mTHPC-Loaded Extracellular Vesicles Significantly Improve mTHPC Diffusion and Photodynamic Activity in Preclinical Models
por: Millard, Marie, et al.
Publicado: (2020) -
Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts
por: Ris, H-B, et al.
Publicado: (1999) -
Lipid‐DNAs as Solubilizers of mTHPC
por: Liu, Yun, et al.
Publicado: (2017) -
Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC).
por: Mikvy, P., et al.
Publicado: (1997)